Page last updated: 2024-10-30

lorazepam and Glioblastoma

lorazepam has been researched along with Glioblastoma in 2 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research Excerpts

ExcerptRelevanceReference
"He was diagnosed with catatonia and treated successfully with lorazepam."1.51Temporal glioblastoma presenting as catatonia. ( Franssen, A; Sienaert, P, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franssen, A1
Sienaert, P1
Lukovits, TG1
Fadul, CE1
Pipas, JM1
Williamson, PD1

Other Studies

2 other studies available for lorazepam and Glioblastoma

ArticleYear
Temporal glioblastoma presenting as catatonia.
    BMJ case reports, 2019, Mar-04, Volume: 12, Issue:3

    Topics: Anti-Anxiety Agents; Catatonia; Chemotherapy, Adjuvant; Depression; Glioblastoma; Humans; Lorazepam;

2019
Nonconvulsive status epilepticus after intravenous contrast medium administration.
    Epilepsia, 1996, Volume: 37, Issue:11

    Topics: Brain Neoplasms; Contrast Media; Diatrizoate Meglumine; Electroencephalography; Glioblastoma; Humans

1996